Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...
For children diagnosed with complex heart conditions like hypertrophic cardiomyopathy (HCM), the diagnosis can be frightening for families and challenging for healthcare providers since the trajectory of the condition is often uncertain. As a leading cause of sudden...
An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
Journey to Re-envisioning Access to Health Data
James is a licensed carpenter, quantum scientist and health-tech entrepreneur who is motivated by solving novel transformative problems. First joining as a partner in his family carpentry business, he built houses for 9 years until his strong interest in quantum physics led him to the University of Toronto. There he studied Engineering Science, majoring in physics and completed his masters with top publications in physical review letters and APS Physics. During his PhD, James partnered with co-founder Derrick Chow to found Medchart on a mission to eliminate barriers to access and control of one’s health information after experiencing the pains of interacting with archaic health information systems while his father-in-law was ill. As CEO, he has successfully grown MEdchart across the USA and Canada and attracted world-class investors to accelerate growth. He continues to grow Medchart today and is on a mission to radically re-envision access to health data.
Please use the following link to register in advance of the webinar:
https://us02web.zoom.us/meeting/register/tZcvdu6grz0oHNdqyb2WDkaFw9f3JzdLyfV_